ARTICLE | Cover Story
Expanding platinum's potential
December 11, 2008 8:00 AM UTC
Researchers at Northern Illinois University and Ohio University have identified a new class of platinum complexes that exhibit anticancer activity without binding to DNA.1Although platinum-based cancer therapeutics are generally believed to work by binding DNA, this paper shows that these drugs may exert at least part of their effects through other mechanisms.
According to the researchers, the findings may lead to next-generation platinum-based cancer therapeutics with fewer side effects and less potential for drug resistance than marketed platinum drugs...